PODCAST

PART I: Lecture

PART II: Discussion

Calendar of Events

September 2015
S M T W T F S
30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3

Archives

In Loving Memory




IOMSN
International Organization of MS Nurses PDF Print E-mail
Written by Administrator2   

 


  • WEBINAR: Alemtuzumab Clinical Information for Nurses  (LEMTRADA)
    Date: Tuesday - September 15, 2015
    Time: 8:00 PM EST
    Web Log-in: https://event.webcasts.com/starthere.jsp?ei=1073469

  • 2nd Congress of the European Academy of Neurology (EAN)
    Copenhagen, Denmark - May 28-31, 2016
    Website: www.eaneurology.org/copenhagen2016
    Contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

    3rd Congress of the European Academy of Neurology (EAN)
    Amsterdam, The Netherlands - June 24-27, 2017
    Website: www.eaneurology.org/amsterdam2017
    Contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

  • Counseling Points: SPRING 2015 Volume 10, Number 4
    Encouraging Monitoring and Follow-up in MS Care

  • MOVING FORWARD:
    Adherence to Therapy & the Role of Nursing in MS



  • MS BLUEPRINT, A UNIQUE NEW TOOL FOR THE MS COMMUNITY, HAS LAUNCHED!
    The International Organization of Multiple Sclerosis Nurses (IOMSN) has partnered with Biogen Idec to launch MS Blueprint™, a program to encourage those impacted by MS to set goals, create personalized activity plans called MS Blueprints, and take small steps to attain a more positive life. Learn more.

  • 5TH INTERNATIONAL SYMPOSIUM ON GAIT AND BALANCE  IN MULTIPLE SCLEROSIS: FALL DETECTION and PREVENTION


    When  :
    September 25-26, 2015
    Where : Portland, OR

    This unique highly regarded symposium brings together multidisciplinary professionals from around the world to discuss and disseminate information and develop collaborations to advance research and patient care related to gait and balance dysfunction in people with multiple sclerosis.  

    For more information, please visit: www.ohsubrain.com/msgait

  • MS COALITION: The Use of Disease-Modifying Therapies in MS
    The member organizations of the Multiple Sclerosis Coalition have collaborated to summarize the current evidence about disease modification in multiple sclerosis (MS) and to provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people.






 

IOMSN Endorsement Policy




Regional Meetings


Nurses' Experiences







Reference Materials Links